Philips shares rocket 46% as firm settles U.S. respiratory device case

Philips shares soared Monday after the company agreed a $1.1 billion settlement in a U.S. case linked to the recall of some of its sleep apnea devices.

#newsonleo #phillips #settlement

Philips' U.S. sales of sleep apnea devices face years-long halt after FDA deal Dutch health technology company Philips will not sell new devices to treat sleep apnea in the U.S. as it works to comply with an FDA settlement.

#newsonleo #business #phillips

#powell signaling the rate hikes might not be done.

Of course they arent. The #fed is reading the useless #phillips curve.